Target intelligence / Profile preview

Host mucosal immune response

Molecular classification
Other (multicomponent physiological process), Immune cell populations (includes T cells, B cells, innate lymphoid cells, dendritic cells), Antibody family (primarily immunoglobulin A [IgA]), Lymphoid tissue (MALT, GALT [gut-associated], NALT [nasopharyngeal])
01

Overview

The host mucosal immune response is a complex system consisting of innate and adaptive immune mechanisms operating at mucosal surfaces such as the respiratory, gastrointestinal, and urogenital tracts. It relies on the coordinated activities of mucosal immune cells (including dendritic cells, innate lymphoid cells, tissue-resident memory T cells), mucosa-associated lymphoid tissues (like GALT and NALT), and specialized antibodies (mainly IgA) to provide rapid and localized defense against pathogens. Additionally, mucosal immunity can induce systemic immune reactions and plays a crucial role in regulating tolerance to commensal microbes and food antigens. Because the mucosal immune response is not a single molecule or receptor, but rather a protective system, it is not considered a canonical therapeutic target, but can be modulated or enhanced by vaccines and immunotherapies designed to induce robust mucosal defenses. For structured molecular target databases, this entry should be flagged as incorrect/missing specificity, as it is a process, not a molecule or receptor. If specific molecular targets within the host mucosal immune response (such as IgA, pIgR, or memory T cells) are sought, those should be listed separately.

Other names
Mucosal immunityMucosal immune systemMALT (mucosa-associated lymphoid tissue)mucosal defense
02

Biological functions

Immune response (especially at mucosal surfaces)Local and systemic immunityPathogen neutralization/barrier functionInduction of tolerance (to food antigens/microbiota)InflammationAntibody production (notably IgA)
03

Disease associations

Infection (especially respiratory, gastrointestinal, urogenital)Inflammation (e.g., inflammatory bowel disease, chronic airway inflammation)Vaccine response (effectiveness; ability to reduce transmission)Cancer (certain chronic inflammatory diseases may increase cancer risk)Other (autoimmunity and tolerance failure)

Beyond the preview

Go deeper on Host mucosal immune response.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host mucosal immune response.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call